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ABSTRACT
Background: Use ofMRI with diffusion-weighted imaging (DWI) can identify infarcts in 30%–50%
of patients with TIA. Previous guidelines have indicated that MRI-DWI is the preferred imaging
modality for patients with TIA. We assessed the frequency of MRI utilization and predictors of MRI
performance.
Methods: A review of TIA and minor stroke patients evaluated at Veterans Affairs hospitals was
conducted with regard to medical history, use of diagnostic imaging within 2 days of presentation,
and in-hospital care variables. Chart abstraction was performed in a subset of hospitals to assess
clinical variables not available in the administrative data.
Results: A total of 7,889 patients with TIA/minor stroke were included. Overall, 6,694 patients
(84.9%) had CT or MRI, with 3,396/6,694 (50.7%) having MRI. Variables that were associated
with increased odds of CT performance were age .80 years, prior stroke, history of atrial fibril-
lation, heart failure, coronary artery disease, anxiety, and low hospital complexity, while blood
pressure .140/90 mm Hg and high hospital complexity were associated with increased likeli-
hood of MRI. Diplopia (87% had MRI, p 5 0.03), neurologic consultation on the day of presenta-
tion (73% hadMRI, p, 0.0001), and symptom duration of.6 hours (74% had MRI, p5 0.0009)
were associated with MRI performance.
Conclusions: Within a national health system, about 40% of patients with TIA/minor stroke had
MRI performed within 2 days. Performance of MRI appeared to be influenced by several patient
and facility-level variables, suggesting that there has been partial acceptance of the previous
guideline that endorsed MRI for patients with TIA. Neurology® 2017;88:237–244
GLOSSARY
AF 5 atrial fibrillation; BP 5 blood pressure; CAD 5 coronary artery disease; CEA 5 carotid endarterectomy; CHF 5
congestive heart failure; DWI 5 diffusion-weighted imaging; ED 5 emergency department; IHD 5 ischemic heart disease;
MI 5 myocardial infarction; VA 5 Veterans Affairs.
In recent years, it has been recognized that some patients with transient neurologic symptoms
will have ischemic brain lesions demonstrated with sophisticated imaging methods.1,2 Therefore,
due to the presence of tissue damage, it has been proposed that patients with imaging evidence of
infarction, despite transient symptoms, should be classified as having had a stroke instead of
TIA.3 A committee of the American Stroke Association also proposed that for patients with
symptoms suggestive of a TIA, MRI with diffusion-weighted imaging (DWI) is the preferred
imaging modality due to increased sensitivity for detection of acute ischemic brain lesions.3
Detection of ischemic lesions in patients with transient symptoms can be useful in the iden-
tification of patients at increased short-term risk of stroke.4–7 In addition, visualization of the
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Table 1 Comparison of baseline characteristics between those who received MRI vs CT without MRI (within 2
days of event) for TIA/minor stroke using administrative data
Overall
(n 5 6,694)
CT without MRI
(n 5 3,298) (49.3%)
MRI (n 5 3,396)
(50.7%) p Value
Age, ya
<60 1,386 (20.7) 617 (18.7) 769 (22.6)
60–<70 2,579 (38.5) 1,197 (36.3) 1,382 (40.7) ,0.0001b
70–<80 1,310 (19.6) 652 (19.8) 658 (19.4)
801 1,419 (21.2) 832 (25.2) 587 (17.3)
Sex
Female 268 (4.0) 134 (4.1) 134 (3.9) 0.8067
Male 6,426 (96.0) 3,164 (95.9) 3,262 (96.1)
Racea
Asian 21 (0.3) 12 (0.4) 9 (0.3) ,0.0001b
Black 1,410 (21.4) 608 (18.7) 802 (24.0)
Hispanic 138 (2.1) 82 (2.5) 56 (1.7)
North American Native 40 (0.6) 20 (0.6) 20 (0.6)
Other 71 (1.1) 32 (1.0) 39 (1.2)
White 4,923 (74.6) 2,501 (76.8) 2,422 (72.3)
Missing 91 43 48
Obesity (ICD-9 code of 278.01) 358 (5.3) 194 (5.9) 164 (4.8) 0.0555
History of hypertension 5,422 (81.0) 2,706 (82.0) 2,716 (80.0) 0.0306
Diabetes 2,732 (40.8) 1,373 (41.6) 1,359 (40.0) 0.1793
Hyperlipidemia 4,818 (72.0) 2,412 (73.1) 2,406 (70.8) 0.0372
Current smoker 2,286 (34.1) 1,040 (31.5) 1,246 (36.7) ,0.0001b
Strokea 1,951 (29.1) 1,063 (32.2) 888 (26.1) ,0.0001b
MIa 1,009 (15.1) 572 (17.3) 437 (12.9) ,0.0001b
Atrial fibrillationa 831 (12.4) 503 (15.3) 328 (9.7) ,0.0001b
CHFa 1,428 (21.3) 832 (25.2) 596 (17.6) ,0.0001b
Dementiaa 420 (6.3) 263 (8.0) 157 (4.6) ,0.0001b
CEA or stent 424 (6.3) 234 (7.1) 190 (5.6) 0.0117b
CAD/IHD 2,184 (32.6) 1,220 (37.0) 964 (28.4) ,0.0001b
Peripheral vascular disease 1,794 (26.8) 968 (29.4) 826 (24.3) ,0.0001b
Sleep apneaa 1,120 (16.7) 606 (18.4) 514 (15.1) 0.0004b
Depression 2,466 (36.8) 1,293 (39.2) 1,173 (34.5) 0.0001b
Anxiety 1,574 (23.5) 838 (25.4) 736 (21.7) 0.0003b
Recent CEA or stent 68 (1.0) 40 (1.2) 28 (0.8) 0.1132
Charlson Comorbidity Indexa
No. 6,694 3,298 3,396
Mean 6 SD 1.8 6 2.1 1.8 6 2.1 1.7 6 2.1 ,0.0001b
Median (min, max) 1 (0, 15) 1 (0, 15) 1 (0, 14)
Length of stay for those admitted
No. 5,075 1,908 3,167
Mean 6 SD 2.7 6 1.9 2.9 6 2.1 2.6 6 1.9 0.0003b
Median (min, max) 2 (0, 44) 3 (0, 27) 2 (0, 44)
Admitted 5,028 (75.1) 1,890 (57.3) 3,138 (92.4) ,0.0001b
Continued
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ischemic lesion can clarify the anatomical loca-
tion of the patient’s symptoms and may help
elucidate the mechanism of the ischemic pro-
cess (e.g., atherothrombotic, embolic).8
Performance of brain MRI for patients
with stroke has increased by over 200% in rel-
ative terms during 1999–2008.9 Brain MRI
has drawbacks, including anxiety for some
Table 1 Continued
Overall
(n 5 6,694)
CT without MRI
(n 5 3,298) (49.3%)
MRI (n 5 3,396)
(50.7%) p Value
ABCD2 elements
Age ‡60 y 5,209 (77.8) 2,631 (79.8) 2,578 (75.9) 0.0001b
BP ‡140/60 mm Hg 4,133 (62.5) 1,936 (59.8) 2,197 (65.2) ,0.0001b
Diabetes 2,319 (34.6) 1,146 (34.7) 1,173 (34.5) 0.8583
Patient location (event location)
ED 1,619 (24.2) 1,390 (42.1) 229 (6.7) ,0.0001b
Inpatient 5,075 (75.8) 1,908 (57.9) 3,167 (93.3)
Weekend
Weekday 5,443 (81.3) 2,680 (81.3) 2,763 (81.4) 0.9172
Weekend 1,251 (18.7) 618 (18.7) 633 (18.6)
MRI in 6–12 mo pre TIA or stroke 288 (4.3) 138 (4.2) 150 (4.4) 0.6391
Facility level variables
ED FTE per 100,000 0.0229b
No. 6,694 3,298 3,396
Mean 6 SD 14.0 6 12.8 14.0 6 12.2 14.0 6 13.3
Median (min, max) 11.7 (0, 54.6) 13 (0, 54.6) 9.6 (0, 54.6)
Neurology FTE per 100,000 ,0.0001b
No. 6,694 3,298 3,396
Mean 6 SD 9.4 6 5.5 8.7 6 5.3 10.1 6 5.6
Median (min, max) 8.2 (0, 26.9) 7.7 (0, 26.9) 8.8 (0, 26.9)
Facility complexity
High 4,985 (74.5) 2,128 (64.5) 2,857 (84.2) ,0.0001b
Low 497 (7.4) 418 (12.7) 79 (2.3)
Medium 1,211 (18.1) 752 (22.8) 459 (13.5)
Missing 1 0 1
How CT is obtained
In-house 24/7 5,176 (77.3) 2,465 (74.7) 2,711 (79.9) ,0.0001b
In-house limited hours 1,144 (17.1) 605 (18.3) 539 (15.9)
Provided by affiliate or local 373 (5.6) 228 (6.9) 145 (4.3)
Missing 1 0 1
Emergent CT response time
In-house technologist 24/7 1,733 (25.9) 832 (25.2) 901 (26.5) 0.0801
<30 min 2,215 (33.1) 1,062 (32.2) 1,153 (34.0)
31–60 min 2,521 (37.7) 1,286 (39.0) 1,235 (36.4)
>60 min 2,24 (3.3) 118 (3.6) 106 (3.1)
Missing 1 0 1
Abbreviations: BP 5 blood pressure; CAD 5 coronary artery disease; CEA 5 carotid endarterectomy; CHF 5 congestive
heart failure; ED 5 emergency department; FTE 5 full-time equivalent; ICD-9 5 International Classification of Diseases–9;
IHD 5 ischemic heart disease; MI 5 myocardial infarction.
Values are n (%) unless otherwise noted.
aConsidered clinically important to obtaining MRI post TIA or stroke.
bSignificant.
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Table 2 Bivariate and multivariable model for MRI from development sample (n 5 4,418)
Bivariate results Multivariable results
Odds ratio
(95% confidence
interval)
Overall test
p value p Value Estimate (SE)
Odds ratio
(95% confidence
interval)
Overall test
p value p Value
Intercept 20.65 (0.21) 0.0023a
Age, y
<60 Reference ,0.0001 0.00 Reference 0.0014
60–<70 0.93 (0.78–1.11) 0.4272 20.01 (0.09) 0.99 (0.82–1.19) 0.9280
70–<80 0.87 (0.71–1.06) 0.1654 0.01 (0.11) 1.01 (0.81–1.26) 0.9509
801 0.57 (0.47–0.70) ,0.0001 20.35 (0.11) 0.70 (0.56–0.88) 0.0021a
Sex
Female 0.97 (0.70–1.34) 0.8500
Race
Asian 1.19 (0.30–4.77) 0.3240 0.8055 0.23 (0.73) 1.26 (0.30–5.29) 0.9309 0.7558
Black 1.21 (1.02–1.44) 0.0281 0.06 (0.09) 1.06 (0.89–1.27) 0.5050
Hispanic 0.95 (0.59–1.52) 0.8243 20.07 (0.24) 0.93 (0.58–1.51) 0.7737
North American Native 1.46 (0.67–3.20) 0.3438 0.32 (0.41) 1.38 (0.62–3.09) 0.4311
Other 1.11 (0.60–2.06) 0.7335 0.11 (0.33) 1.12 (0.59–2.15) 0.7273
White Reference 0.00 Reference
Obesity 0.92 (0.69–1.24) 0.5977
Hypertension 0.97 (0.82–1.14) 0.6741
Diabetes 0.98 (0.86–1.12) 0.7449
Hyperlipidemia 0.92 (0.80-1.06) 0.2752
Current smoker 1.35 (1.17–1.55) ,0.0001
Stroke 0.66 (0.57–0.76) ,0.0001 20.28 (0.08) 0.76 (0.65–0.88) 0.0005a
MI 0.64 (0.53–0.76) ,0.0001 0.02 (0.12) 1.02 (0.80–1.29) 0.8931
Atrial fibrillation 0.55 (0.45–0.67) ,0.0001 20.29 (0.11) 0.75 (0.60–0.93) 0.0103a
CHF 0.54 (0.46–0.63) ,0.0001 20.30 (0.10) 0.74 (0.61–0.90) 0.0018a
Dementia 0.66 (0.50–0.86) 0.0034 20.12 (0.15) 0.89 (0.66–1.19) 0.4209
CEA or stent 0.60 (0.46–0.79) 0.0004 20.30 (0.15) 0.74 (0.56–0.99) 0.0434a
CAD/IHD 0.61 (0.53–0.71) ,0.0001 20.23 (0.10) 0.79 (0.66–0.96) 0.0159a
Peripheral vascular disease 0.72 (0.62–0.84) ,0.0001
Sleep apnea 0.82 (0.69–0.97) 0.0261 20.09 (0.09) 0.92 (0.76–1.10) 0.3503
Depression 0.84 (0.73–0.96) 0.0116
Anxiety 0.74 (0.64–0.86) 0.0002 20.23 (0.08) 0.80 (0.68–0.93) 0.0051a
Recent CEA stent 0.58 (0.31–1.08) 0.0961
Charlson Comorbidity Index 0.94 (0.91–0.97) 0.0001 0.02 (0.02) 1.02 (0.99–1.06) 0.2452
Length of stay 0.93 (0.89–0.97) 0.0007
Admitted 11.35 (9.30–13.85) ,0.0001
ABCD2 age 0.82 (0.70–0.95) 0.0111
ABCD2 blood pressure 1.40 (1.22–1.60) ,0.0001 0.27 (0.07) 1.31 (1.14–1.50) 0.0002a
ABCD2 DM 1.04 (0.91–1.19) 0.5854
MRI in 6–12 months pre
TIA or stroke
1.01 (0.73–1.38) 0.9754
FTE ED 100,000 1.00 (0.99–1.01) 0.9772
FTE Neurology 100,000 1.08 (1.04–1.11) ,0.0001 0.02 (0.01) 1.02 (0.99–1.05) 0.1494
Continued
240 Neurology 88 January 17, 2017
ª 2016 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.
patients, increased health care costs,9 and
potential discovery of incidental abnormali-
ties.10,11 Widespread adoption of MRI for
TIA/minor stroke could require reconfigura-
tion of neuroimaging services.
We sought to assess how frequently MRI
was performed for patients with TIA
and minor stroke and whether there were
patient- or hospital-level predictors of MRI
performance. We evaluated utilization pat-
terns with the Veterans Affairs (VA) system,
where there are no predefined radiology proto-
cols for brain imaging and clinicians can select
their preferred test with no cost constraints.
METHODS Patients with TIA or minor stroke who were cared
for in either the emergency department (ED) or inpatient setting
during fiscal year 2011 were identified (n 5 8,427) using ICD-9
primary discharge codes for TIA (435.0, 435.1, 435.3, 435.8,
435.9) or stroke (433.X1, 434.00, 434.X1, and 436). As
described elsewhere, because electronic health record data did
not include a measure of stroke severity, a validated approach
to identify major stroke patients was employed. Patients with
stroke were classified as having major stroke if any of the
following were present: length of stay .6 days, ventilator use,
feeding tube use, coma, intensive care unit stay, inpatient
rehabilitation stay prior to discharge, or receipt of thrombolysis.
Because our goal was to create a cohort of patients with TIA
and minor stroke, patients with major stroke were excluded.
We further excluded patients who were admitted from a non-
VA hospital (n5 84), who left against medical advice (n5 100),
who were discharged to hospice (n5 2), who were transferred to
another facility within 2 days (n 5 336), or who died within 2
days (n 5 18). Among the 7,889 patients eligible for inclusion,
an additional 1,195 patients were excluded from the predictive
models because they had a pacemaker (n 5 523) or did not
receive imaging within 2 days of presentation (n 5 1,072),
leaving an analytic cohort of 6,694.
Data collected from this study are described more fully
elsewhere.12 In brief, the VA Medical SAS datasets were used
to obtain information on demographics, medical history, and
health care utilization, including data on cranial imaging.
Data from the VA Corporate Data Warehouse provided infor-
mation on blood pressure (BP) and other patient risk factors,
such as smoking history. Facility-specific data were obtained
from VA internal program offices regarding emergency med-
icine and neurology staffing and hospital complexity, which
classifies facilities into 3 levels based on a combination of
patient characteristics, clinical services offered, educational
and research missions, and administrative complexity. Infor-
mation on services offered in the ED (e.g., CT availability)
were obtained from a national VA-wide survey of ED medical
directors.12
A separate, detailed electronic medical chart review of patients
at select high-volume VA hospitals (a 35% random sample of
facilities with at least 50 TIA or minor stroke patients in fiscal
year 2011) was performed by trained abstractors to obtain clinical
factors (e.g., symptom duration) that were not available from the
administrative data. Patients were included in this medical record
review if they had a diagnosis of either TIA or ischemic stroke.
Patients with ischemic stroke who had a NIH Stroke Scale of
#2 at the time of presentation were considered to have minor
stroke and were therefore included.
Statistical methods. Demographic, medical history, Charlson
Comorbidity Index, and ED/hospitalization descriptors were
Table 2 Continued
Bivariate results Multivariable results
Odds ratio
(95% confidence
interval)
Overall test
p value p Value Estimate (SE)
Odds ratio
(95% confidence
interval)
Overall test
p value p Value
Facility Complexity
High 2.98 (2.13–4.17) ,0.0001 ,0.0001 1.01 (0.19) 2.76 (1.90–4.00) ,0.0001 ,0.0001a
Medium Reference 0.00 Reference
Low 0.32 (0.19–0.55) 0.0001 21.14 (0.28) 0.32 (0.18–0.56) 0.0001a
How obtained CT
In-house 24/7 1.77 (0.85–3.68) 0.1527 0.1313
In-house limited hours 1.22 (0.53–2.80) 0.6353
Provided by affiliate or local Reference
Emergent CT response time
<30 min 0.86 (0.49–1.50) 0.6090 0.5905
31–60 min 0.76 (0.45–1.29) 0.3122
>60 min 0.52 (0.17–1.60) 0.2579
In-house technologist 24/7 Reference
Abbreviations: BP 5 blood pressure; CAD 5 coronary artery disease; CEA 5 carotid endarterectomy; CHF 5 congestive heart failure; DM 5 diabetes
mellitus; ED 5 emergency department; FTE 5 full-time equivalent; ICD-9 5 International Classification of Diseases–9; IHD 5 ischemic heart disease; MI 5
myocardial infarction.
a Significant.
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compared between those who received MRI and those who
received CT without MRI by using x2, Fisher exact test, or
Wilcoxon rank-sum test. Differences in facility characteristics
were also compared using these same tests.
A predictive model using administrative data was built for
performance of MRI (present or absent). For the development
group, two-thirds of the sample was randomly chosen and the
remaining third was used for validation. Bivariate logistic regres-
sion models were used to assess associations between patient and
facility characteristics and the log odds ratio of receiving MRI in
2 days. The logistic model included a random intercept for facil-
ity, which was incorporated into the model for the correlation of
patients from the same hospital. Clinically important variables
were selected for inclusion in a multivariable logistic model
regardless of statistical significance in bivariate models. These
were age, race, history of stroke, myocardial infarction (MI),
atrial fibrillation (AF), congestive heart failure (CHF), and
dementia. Other covariates were chosen based on a variable
selection method; if they were significant at the 0.25 level in
bivariate models, they were eligible for inclusion into the multi-
variable regression model. Backwards variable selection was
used with staying criteria of 0.05 to eliminate variables. The
C-statistic for the resulting model was calculated. The resulting
model was fit to the validation sample and the C-statistic was
reported as a measure of model performance. Analyses were
generated using SAS/STAT software, version 9.2, of the SAS
System for Windows (SAS Institute, Cary, NC). Institutional
review board approval was obtained.
RESULTS A total of 8,427 patients with TIA
or minor stroke were cared for in a VA ED or inpa-
tient setting in fiscal year 2011. We examined imag-
ing among the 7,889 patients eligible for analysis. A
total of 6,694 (84.9%) had cranial imaging (either
CT or MRI) performed within 2 days of presenta-
tion (table 1), with 3,298 (49.3%) having CT with-
out MRI and 3,396 (50.7%) having MRI. Using
the administrative data, we saw in bivariate analyses
that the clinically important variables that were
selected a priori were significantly associated with
CT performance rather than MRI: age .80 years
(58.6% with CT only, 41.4% MRI), prior stroke
(54.5% CT, 45.5% MRI), prior MI (56.7% vs
43.3%), AF (60.5% CT, 39.5% MRI), dementia
(62.6% CT, 37.4% MRI), and CHF (58.3% CT,
41.7%MRI) (p, 0.0001 for each; table 1). Among
hospital characteristics, greater availability of CT on
a 24/7 basis, higher hospital complexity, and greater
neurology staffing levels were associated with
increased MRI performance (tables 2 and 3).
Between fiscal year 2011 and fiscal year 2014, the
use of MRI without CT increased from 9.7% in
2011 to 12.0% in 2014 (p , 0.0001). The use of
brain or carotid imaging was slightly higher for TIA
patients compared to minor stroke (93.0% vs
86.3%, p , 0.0001).
On chart review, diplopia as a complaint (87%
with diplopia had MRI vs 13% CT only, p 5
0.03), neurologic consultation at presentation (73%
had MRI vs 27% CT only, p , 0.0001), and symp-
tom duration of.6 hours (7% had MRI vs 26% CT
only, p 5 0.0009) were associated with MRI perfor-
mance (table 4). Other symptoms such as weakness,
speech disturbance, or vertigo were not associated
with MRI performance.
The multivariable modeling fit to the develop-
ment set included age, race, prior stroke, prior MI,
history of AF, CHF, dementia, sleep apnea, Charlson
Comorbidity Index, history of carotid endarterec-
tomy (CEA) or stent, coronary artery disease/ische-
mic heart disease (CAD/IHD), anxiety, ABCD2
score for BP $140/90 mm Hg, neurologist availabil-
ity (number of full-time equivalent employees per
100,000 patients), and hospital complexity. Explan-
atory variables associated with increased likelihood of
MRI were BP $140/90 mm Hg and high hospital
complexity, while age .80 years, prior stroke, AF,
CHF, history of CEA or stent, CAD/IHD, anxiety,
and low hospital complexity were associated with
decreased likelihood of MRI. When this model was
fit to the validation set, AF, dementia, sleep apnea,
and low hospital complexity were associated with
reduced likelihood of receiving a MRI, while
neurologist availability and high hospital complexity
were associated with an increased chance of MRI
Table 3 Hospital characteristics and imaging results
Facility level variables Total CT only MRI p Value
ED FTE per 100,000
No. 6,694 3,298 3,396
Mean 6 SD 14.0 6 12.8 14.0 6 12.2 14.0 6 13.3 0.0229a
Median (min, max) 11.7 (0, 54.6) 13 (0, 54.6) 9.6 (0, 54.6)
Neurology FTE per 100,000
No. 6,694 3,298 3,396
Mean 6 SD 9.4 6 5.5 8.7 6 5.3 10.1 6 5.6 ,0.0001a
Median (min, max) 8.2 (0, 26.9) 7.7 (0, 26.9) 8.8 (0, 26.9)
Complexity
Missing 1 1 0
High 4,985 (74.5) 2,128 (64.5) 2,857 (84.2) ,0.0001a
Medium 497 (7.4) 418 (12.7) 79 (2.3)
Low 1,211 (18.1) 752 (22.8) 459 (13.5)
CT availability 1 0 1
In house 24/7 5,176 (77.3) 2,465 (74.7) 2,711 (79.9) ,0.0001a
In house, limited hours 1,144 (17.1) 605 (18.3) 539 (15.9)
Provided by affiliate or local 373 (5.6) 228 (6.9) 145 (4.3)
Emergent CT response time 1 0 1
Technologist available
in-house 24/7
1,733 (25.9) 832 (25.2) 901 (26.5) 0.0801
Less than 30 min 2,215 (33.1) 1,062 (32.2) 1,153 (34.0)
31–60 min 2,521 (37.7) 1,286 (39.0) 1,235 (36.4)
Abbreviations: ED 5 emergency department; FTE 5 full time equivalent.
a Significant.
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performance. The C-statistic for the development
sample was 0.74 and for the validation set was 0.76.
DISCUSSION We sought to determine the extent to
which MRI is being performed for patients with TIA
and minor stroke within a large, national integrated
health system. We found that MRI was performed
within 2 days of initial presentation in about 51%
of patients in whom imaging was performed. Several
clinical features were more common among patients
who were imaged with CT only, whereas other
patient and facility characteristics were more frequent
among patients receiving MRI.
In terms of patient features that were more fre-
quent in the population with CT only, several char-
acteristics were indicative of greater comorbidity
burden. Elderly patients, those with prior stroke,
those with dementia, and those with AF or CHF
were all more likely to have a CT only. This may
reflect the treating physician’s desire to not burden
a sick population with excessive testing. In addition,
if the patient’s functional status is limited, then the
results of MRI may not influence treatment deci-
sions.13 A previous study from a German TIA reg-
istry also found that younger patients and patients
without AF were more likely to have a brain MRI
performed.14
The chart review portion of the analysis found that
diplopia was more frequent in patients who had an
MRI. Diplopia as a manifestation of TIA or stroke
suggests ischemia in the vertebrobasilar circulation,
especially in the midbrain or pons. Because the areas
supplied by the vertebral and basilar arteries, particu-
larly the brainstem and cerebellum, are better visual-
ized with MRI as opposed to CT, it makes clinical
sense to prefer imaging with MRI in patients with
diplopia as a presenting complaint.15 The clinical
yield of imaging in patients with new-onset, isolated
diplopia has been questioned, however. In a series of
93 patients over age 50 years with new onset of dip-
lopia and no other neurologic abnormalities, only one
patient had a relevant lesion on MRI.16
Involvement of neurologists was more common in
patients who underwent brain MRI. In previous
stroke studies, involvement of neurologists was associ-
ated with better outcomes but more extensive testing,
especially ordering of brain MRI scans.17 It is possible
that neurologists are more aware of clinical guidelines
recommending MRI for patients with TIA-like pre-
sentations and that neurologists are more cognizant of
the relationship between ischemic lesions on DWI
and future stroke risk.18 In a recent multicenter study
of patients with TIA or minor stroke, MRI was per-
formed in 58.5% of patients and multiple acute in-
farcts were associated with a higher rate of recurrent
cerebrovascular events.19
Patients with symptom duration of more than 6
hours were more likely to receive brain imaging with
MRI. This could be due to the fact that longer-lasting
symptoms are more likely to have an imaging corre-
late on brain MRI.3,8 In addition, patients with
longer-lasting symptoms are more likely to be admit-
ted to the hospital, which could in turn lead to addi-
tional diagnostic testing.
Our study has several limitations. First, the larger
administrative dataset did not allow us to ascertain
some clinical variables that may have influenced the
imaging strategy, such as whether the symptoms were
referable to the anterior or posterior circulation; these
variables were available only in the smaller chart
review component. Second, some facilities within
the large VA system lack access to MRI on a 7-day-
per-week basis, which may have affected the imaging
choices. Third, the administrative database did not
allow us to determine the clinical utility of having
the MRI in addition to CT.13 In addition, the avail-
able data do not indicate whether DWI was routinely
done as part of the MRI protocol. The study results
are generalizable to medium and large community
hospitals in the United States but they may not be
generalizable to comprehensive stroke centers that
have continuous MRI availability. Finally, there
may be other confounding variables that affected
Table 4 Predictors of MRI vs CT without MRI using chart review data
Overall
(n 5 663)
CT without
MRI (n 5 236)
(35.6%)
MRI (n 5 427)
(64.4%) p Value
ABCD2 elements
Weakness 344 (51.9) 117 (34.0) 227 (66.0) 0.3763
Speech disturbance
without weakness
287 (43.3) 107 (37.3) 180 (62.7) 0.4282
ABCD2 score total 0.5634
No. 663 236 427
Mean 6 SD 4.0 6 1.5 4.1 6 1.6 4.0 6 1.5
Median (min, max) 4 (0, 7) 4 (0, 7) 4 (0, 7)
Posterior circulation
symptoms
Vertigo 38 (5.7) 11 (28.9) 27 (71.1) 0.3780
Double vision (diplopia) 26 (3.9) 4 (15.4) 22 (84.6) 0.0281a
Neurology consult in the ED 369 (55.7) 104 (28.2) 265 (71.8) ,0.0001a
Symptomatic on
presentation
330 (49.8) 92 (27.9) 238 (72.1) ,0.0001a
Duration of symptoms, h 0.0022a
<1 170 (37.9) 73 (42.9) 97 (57.1)
1–6 142 (31.6) 67 (47.2) 75 (52.8)
>6 137 (30.5) 38 (27.7) 99 (72.3)
Abbreviation: ED 5 emergency department.
Values are n (row %).
a Significant.
Neurology 88 January 17, 2017 243
ª 2016 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.
choice of imaging tests that we were not able to eval-
uate, such as clinician views on the value of MRI in
patients with TIA-like symptoms.20
We found in a national, integrated health system
that MRI within 2 days of event was performed in
about 51% of patients who presented with a TIA or-
minor stroke and had brain imaging performed. This
finding suggests that there has been partial acceptance
of the previous recommendation that brain MRI is
the preferred imaging test for patients with TIA-like
symptoms. Future studies should address the clinical
utility of brain MRI in this patient population.
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